After finishing at $95.20 in the prior trading day, Illumina Inc (NASDAQ: ILMN) closed at $94.32, down -0.92%. In other words, the price has decreased by -$0.88 from its previous closing price. On the day, 6937965 shares were traded. ILMN stock price reached its highest trading level at $96.16 during the session, while it also had its lowest trading level at $92.69.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Ratios:
Our goal is to gain a better understanding of ILMN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 88.63. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Canaccord Genuity on November 10, 2023, Downgraded its rating to Hold and sets its target price to $120 from $210 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 07 when Hoyt Aimee L sold 315 shares for $112.84 per share. The transaction valued at 35,545 led to the insider holds 8,314 shares of the business.
TOUSI SUSAN H sold 500 shares of ILMN for $83,520 on Aug 22. The SVP, Chief Commercial Officer now owns 45,524 shares after completing the transaction at $167.04 per share. On Jul 24, another insider, TOUSI SUSAN H, who serves as the SVP, Chief Commercial Officer of the company, sold 500 shares for $190.08 each. As a result, the insider received 95,040 and left with 46,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 14.98B and an Enterprise Value of 16.32B. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.35 while its Price-to-Book (P/B) ratio in mrq is 2.53. Its current Enterprise Value per Revenue stands at 3.65 whereas that against EBITDA is -26.28.
Stock Price History:
The Beta on a monthly basis for ILMN is 1.08, which has changed by -57.97% over the last 52 weeks, in comparison to a change of 14.28% over the same period for the S&P500. Over the past 52 weeks, ILMN has reached a high of $238.55, while it has fallen to a 52-week low of $89.00. The 50-Day Moving Average of the stock is 124.78, while the 200-Day Moving Average is calculated to be 180.87.
Shares Statistics:
The stock has traded on average 1.92M shares per day over the past 3-months and 3.79M shares per day over the last 10 days, according to various share statistics. A total of 158.80M shares are outstanding, with a floating share count of 158.12M. Insiders hold about 0.43% of the company’s shares, while institutions hold 92.57% stake in the company. Shares short for ILMN as of Oct 30, 2023 were 5.18M with a Short Ratio of 5.18M, compared to 5.64M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.27% and a Short% of Float of 3.66%.
Earnings Estimates
Its stock is currently analyzed by 15 different market analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.11, while EPS last year was $0.14. The consensus estimate for the next quarter is $0.08, with high estimates of $0.29 and low estimates of -$0.23.
Analysts are recommending an EPS of between $0.83 and $0.46 for the fiscal current year, implying an average EPS of $0.66. EPS for the following year is $0.96, with 18 analysts recommending between $2.28 and $0.27.
Revenue Estimates
12 analysts predict $1.07B in revenue for the current quarter. It ranges from a high estimate of $1.1B to a low estimate of $1.03B. As of the current estimate, Illumina Inc’s year-ago sales were $1.08B, an estimated decrease of -1.50% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $1.06B, a decrease of -2.90% less than the figure of -$1.50% in the same quarter last year. There is a high estimate of $1.08B for the next quarter, whereas the lowest estimate is $994M.
A total of 18 analysts have provided revenue estimates for ILMN’s current fiscal year. The highest revenue estimate was $4.56B, while the lowest revenue estimate was $4.31B, resulting in an average revenue estimate of $4.44B. In the same quarter a year ago, actual revenue was $4.58B, down -3.00% from the average estimate. Based on 18 analysts’ estimates, the company’s revenue will be $4.51B in the next fiscal year. The high estimate is $5.18B and the low estimate is $4.11B. The average revenue growth estimate for next year is up 1.50% from the average revenue estimate for this year.
